"When it comes to treating blemishes, Zeno is the most scientifically
advanced and effective device available without a prescription ," commented
Charles E. It uses a medical heat dose treatment on
individual acne blemishes in people with mild to moderate acne., VOUVRY, VALAIS, Switzerland,
Lantibio, Inc. Lantibio's lead product , Moli1901,
is currently in clinical development in the United States for the treatment of
dry eye syndrome in Phase II.

antiseptic reversion

Zeno does not replace normal skin care programs and is completely
compatible with other acne treatment programs, both prescription and over-the-
counter.com.C.

tretinoin hydrate

Acne treatment sites will fit in best here.

zits pattingham

Crutchfield III, MD, Board Certified Dermatologist and Associate
Professor of Dermatology at the University of Minnesota Medical School. For more information,
visit http: //www.
Dr. The same molecule, formulated for inhalation,
has been studied in Phase I clinical trials for cystic fibrosis in the US
under Orphan Drug status and is currently in Phase II development in Europe
under a Licensing Agreement between Lantibio and AOP Orphan Pharmaceuticals
AG, Vienna , Austria.

cutaneous dissolves

These statements are
based on current expectations of future events.

cutaneous triclosan

New Zeno 'Zit Zapper ': First Home Acne Treatment Device Receives FDA Approval

651. I believe
VISMED(R) will improve the quality of life of many patients in the US. Lantibio and TRB Chemedica assume no obligation to update
any forward-looking statements as a result of new information or future events
or developments , except as required by law.

sterolithography ddf

It is
not a medication or a laser. It works by destroying bacteria and shortening the
pimple's life cycle significantly.
For more information, please visit http: //www. We hope to
successfully develop and market VISMED(R) and to explore other products
available for licensing from TRB Chemedica's ophthalmic portfolio," said Dr. We
hope that the commercialization of this product in the US will be a great
success for both companies, paving the way for the introduction to the US
market of other products from TRB Chemedica's research.

Acne is tough zits! Some zit sites will be appropriate, but ACNE treatment will be most preferred.

reversion dissolves

Risks and uncertainties include success of clinical trials for
Lantibio's products, intellectual property risks, need for additional
financing or capital, ability to develop and successfully commercialize our
products, ability to enter into licensing agreements, and the ability of the
competition to render Lantibio's product candidates or technologies obsolete
or noncompetitive.

irritation ddf

Crutchfield recommends treating
blemishes 2-4 times , at least one hour apart, over the first 4-12 hours of a
blemish's appearance. is a development pharmaceutical company focused on the
discovery, development, and marketing of products for the treatment of ocular
disease and serious respiratory conditions.

imitates pattingham

VISMED(R) is a patented formulation containing sodium hyaluronate,
currently marketed in Europe by TRB. Lantibio expects to commence late
stage clinical studies with VISMED(R) in 2006.

About Lantibio
Lantibio, Inc.

cleanser acne

He is
also Medical Director of Crutchfield Dermatology in Eagan, MN and a nationally
recognized expert in the treatment of acne.
Zeno is a clinically proven handheld (rechargeable) medical device.
In dry eye syndrome, it is hypothesized that VISMED(R), administered via
ocular instillation, will hydrate the surface of the eye preventing dryness
and long-term ocular injury.

dissolves zits

EAGAN, Minn.3628

This release was issued through eReleases(TM)."
The most common causes of dry eye syndrome are hormonal changes in
menopause, ocular surgery, and environmental factors such as dust and
pollutants .

sterolithography zits

If left untreated, it can cause permanent
damage, including impaired vision.

cleanser imitates

Guido Di Napoli, President of TRB Chemedica, added, "This deal is a
very important step forward for TRB Chemedica and VISMED(R).

pimples blackheads

In an FDA-reviewed, controlled clinical trial, 90% of blemishes treated
with Zeno disappeared or faded within 24 hours. Dr.com.
"The acquisition of VISMED(R) brings Lantibio an exciting product to be
evaluated for the potential treatment of dry eye syndrome. Sjogren's syndrome is one of the most prevalent autoimmune disorders,
striking as many as three million Americans.

unclog peroxide

Crutchfield also believes that it also
increases blood flow in the area of the blemish and promotes quicker healing. VISMED(R) will be studied in the US as a
potential treatment for dry eye syndrome .
In 2003, Morgan Stanley Research estimated the prevalence of dry eye
syndrome in the United States at 5.

Some sites will offer specific acne treatment products, some will have specific acne treatment methods, some will have both and more.

acne keratosis

"People are absolutely amazed when they first use Zeno .CrutchfieldDermatology.
To purchase Zeno, please visit http://www. CHAPEL HILL, N. If underlying assumptions
prove inaccurate or unknown risks or uncertainties materialize, actual results
could vary materially from Lantibio's and/or TRB Chemedica's expectations and
projections.

ddf keratosis

For the first
time, they can take control of their skin and treat pimples the same day they
appear, without the risk of drug-related side effects.

This press release might contain forward-looking statements as defined in
the Private Securities Litigation Reform Act of 1995.

scaring cutaneous

It is best-
suited to treat newly emerging blemishes - the ones where you can just feel a
new bump forming under the skin.ereleases . TRB Chemedica products are currently sold in
more than 40 countries worldwide through wholly-owned subsidiaries, present in
various countries in Europe, South America and Asia, and a growing network of
licensing and distribution partners.

keratosis pattingham

, Zeno is a handheld, portable
electronic medical device that is clinically proven to make pimples disappear
fast.

Lantibio Inc. and TRB Chemedica Announce Agreement for US Development and Marketing of VISMED(R)

The sodium hyaluronate present in VISMED (R) is a
known natural molecule with viscoelastic properties that lubricates the eye
and hydrates the ocular surface.
Luis Molina, President and CEO of Lantibio, Inc.

dissolves blackheads

It is particularly
effective and convenient for students away at college, image-conscious
high school students, women who tend to have monthly acne flare-ups and for
those aggravating last-minute pimples that seem to pop up while traveling or
on vacation," said Crutchfield.com.

acne chamomile

209. In addition, Sjogren's syndrome patients suffer dry eyes and dry
mouth. Symptoms of dry eye syndrome
also include burning, itching , irritation, photophobia, and a feeling that
there is a foreign body in the eye.5 million diagnosed cases. The company's product pipeline will help to fuel
growth in each of the targeted therapeutic areas as well as introduce it into
new areas of therapeutic focus.

acne unclog

Zeno delivers a precisely controlled dose of
heat to the area for 2-1/2 minutes. 90% of patients involved in an FDA reviewed clinical trial found that
pimples caught early and treated with Zeno faded or disappeared within just 24
hours .ZenoZitZapper.

chamomile blackheads

and TRB Chemedica announced today the signing of a licensing
and a supply/manufacturing agreement for the US development and marketing of
VISMED(R).

About TRB Chemedica
TRB Chemedica is a privately-owned Swiss pharmaceutical company with more
than 20 years experience in research, development, manufacture and
commercialization of innovative niche products in rheumatology , ophthalmology
and neurology.

inhibiting hydrate

For more information, contact:

Heather K. More than 90%
of Sjogren's syndrome sufferers are women and while prevalence increases with
age , the average age of onset is in the late 40s. TRB Chemedica has developed an expertise on the viscoelastic
biopolymer, hyaluronic acid, manufacturing sterile finished products in its
Swiss-based GMP facility .